How QUOSA helps with literature screening. Without a suitable process for PV literature screening, drug safety insights are difficult to find — mainly when working to a regulatory deadline. There is a vast and growing library of medical literature to be searched.
In addition, QUOSA supports searches performed on subscription services, including Embase, ScienceDirect, PubMed and others. For pharmacovigilance teams seeking a more tailored way to monitor adverse drug events in medical literature faster and more efficiently, QUOSA PV centralises, organises and automates the literature review process.
In addition, QUOSA supports searches performed on subscription services, including Embase, ScienceDirect, PubMed and others. For pharmacovigilance teams seeking a more tailored way to monitor adverse drug events in medical literature faster and more efficiently, QUOSA PV centralises, organises, and automates the literature review process.
QUOSA supports searches of subscription services, allowing a centralized way to store and organize documents in a secure, compliant, cloud-based environment. For pharmacovigilance teams, QUOSA promotes efficiency and compliance by centralizing the discovery of adverse drug reactions information in medical literature as well as automating …
9/15/2016 · Elsevier , a world-leading provider of scientific, technical and medical information products and services, today announced it has updated its pharmacovigilance ( PV ) portfolio with the launch of QUOSA PV . This new version of Elsevier ‘s QUOSA literature management solution is specifically designed for the monitoring and review of scientific …
QUOSA PV can monitor Elsevier and non- Elsevier literature databases, conference document databases, and journal RSS feeds. What’s more, it automatically de-duplicates content, significantly reducing reviewing time. Rapid assessment of articles QUOSA PV .
Elsevier Launches QUOSA PV to Help Pharma Companies Improve Literature Monitoring for Pharmacovigilance News provided by. Elsevier Sep 14, 2016, 06:32 ET. Share this article.
